METHODS AND COMPOSITIONS FOR SUBSTITUTED AXIALLY-CHIRAL CANNABINOL ANALOGS

MACROCYCLIC RIP2-KINASE INHIBITORS

SUBSTITUTED AZACYLES AS TRPM8 MODULATORS

SOLID FORMS OF ENANTIOPURE DEUTERIUM-ENRICHED BUPROPION AND METHODS OF USE THEREOF

PROCESS OF MAKING DERIVATIVES OF SUBSTITUTED MORPHOLINES

HETEROCYCLIC DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THE TREATMENT OR AMELIORATION OF CANCER

PROCESSES FOR PREPARING NITROSYLATED PROPANEDIOLS, COMPOSITIONS COMPRISING THE SAME, AND MEDICAL USES THEREOF

COMPOSITIONS AND METHODS FOR TREATING CANCER

SHORT-ACTING BENZODIAZEPINE SALTS AND THEIR POLYMORPHIC FORMS

PROTEIN DEGRADATION AGENT COMPOUND PREPARATION METHOD AND APPLICATION

PROCESS FOR SYNTHESIS OF GALBULIMIMA ALKALOID 18 AND COMPOUNDS USEFUL AS OPIOID RECEPTOR ANTAGONISTS AND AGONISTS

PROCESS FOR PRODUCING ACYLOXYMETHYL ESTERS OF (4S)-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAPHTHYRIDIN-3-CARBOXYLIC ACID

USE OF (2R, 6R)-HYDROXYNORKETAMINE, (S)-DEHYDRONORKETAMINE AND OTHER STEREOISOMERIC DEHYDRO AND HYDROXYLATED METABOLITES OF (R,S)-KETAMINE IN THE TREATMENT OF DEPRESSION AND NEUROPATHIC PAIN

Diamine Derivatives as Inhibitors of Leukotriene A4 Hydrolase

FORMULATIONS COMPRISING N-SUBSTITUTED-DIOXOCYCLOBUTENYLAMINO-3-HYDROXY-PICOLINAMIDE COMPOUNDS AND USES THEREOF

MITOCHONDRIOTROPIC HETEROARYL BENZAMIDE POTASSIUM CHANNEL KV1.3 INHIBITORS

EGFR INHIBITORS

DRUG DELIVERY SYSTEM COMPRISING MONOMETHYL FUMARATE

BCL-2 Inhibitor

PROCESS FOR THE PREPARATION OF 2-CYANOETHYL (4S)-4-(4-CYANO-2-METHOXY-PHENYL)-5-HYDROXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAPHTHYRIDIN-3-CARBOXYLATE BY RACEMATE SEPARATION BY MEANS OF DIASTEREOMERIC TARTARIC ACID ESTERS

MOLECULAR EDITING OF MULTIPLE C-H BONDS LEVERAGING RECOGNITION OF DISTANCE, GEOMETRY AND CHIRALITY

HETEROCYCLIC COMPOUNDS AS MODULATORS OF MGLUR7

ANTI-INFLUENZA VIRUS PYRIMIDINE DERIVATIVES

PROCESS

DEUTERATED TRYPTAMINE DERIVATIVES AND METHODS OF USE

TRICYCLIC BORONIC ACID DERIVATIVE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

DIARYL MACROCYCLE POLYMORPH

ENANTIOMERICALLY PURIFIED GPER AGONIST FOR USE IN TREATING DISEASE STATES AND CONDITIONS

PROCESS FOR PREPARING OCTAHYDRO-2(1H)-NAPHTHALENONE DERIVATIVES

(R)-2-[(2H-1,3-BENZODIOXOL-5-YL)METHYL]PYRROLIDINE AND PROCESSES FOR PREPARATION, COMPOSITIONS AND USES THEREOF

COVALENT INHIBITORS OF KRAS

GLYCOSYL DONOR, PREPARATION METHOD THEREFOR, AND USE THEREOF

DEUTERATED TRYPTAMINE DERIVATIVES AND METHODS OF USE

PROCESS FOR RACEMIZING AND ISOLATING ATROPISOMERS OF 7-CHLORO-6-FLUORO-1-(2-ISOPROPYL-4-METHYLPYRIDIN-3-YL)PYRIDO[2,3-D]PYRIMIDINE-2,4(1H,3H)-DIONE

ANTIBACTERIAL AGENTS: SOLUBLE SALTS AND AQUEOUS FORMULATIONS OF PYRONINS

IRAK4 DEGRADERS AND SYNTHESIS THEREOF

PICOLINAMIDES AS FUNGICIDES

PARTIALLY DEUTERATED 1,4-PHENYLENEDIAMINE-D4 AND PREPARATION METHOD AND USE THEREOF

Polyol-Derived Compounds

Optically Active Segment for Use in Synthesis of Stereocontrolled Oligonucleotide, Method for Producing the Same, and Method for Synthesizing Stereocontrolled Oligonucleotide Using the Same

DEUTERATED TRYPTAMINE DERIVATIVES AND METHODS OF USE

MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

DERIVATIVES OF SOBETIROME

METHODS OF TREATING NEUROLOGICAL AND OTHER DISORDERS USING ENANTIOPURE DEUTERIUM-ENRICHED BUPROPION

COMPOSITION AND METHODS OF USE OF NOVEL PHENYLALANINE SMALL ORGANIC COMPOUNDS TO DIRECTLY MODULATE PCSK9 PROTEIN ACTIVITY

SOLID FORM OF (-)-AMBROX FORMED BY A BIOCONVERSION OF HOMOFARNESOL IN THE PRESENCE OF A BIOCATALYST

Phthalazinone compound, and preparation method therefor and medical use thereof

ISOQUINOLINONES AND QUINOLINONES AS MODULATORS OF POLRMT

AMINES FOR USE AS SIGMA RECEPTOR MODULATORS

MECHANOPHORE WITH FORCE TRIGGERED STEREOCHEMISTRY CONVERSION

BCL-2 Inhibitor

PROCESS FOR THE PRODUCTION OF LEVETIRACETAM AND INTERMEDIATE THEREOF

Polyol-Derived Compounds

(R)-2-[(2H-1,3-BENZODIOXOL-5-YL)METHYL]PYRROLIDINE AND PROCESSES FOR PREPARATION, COMPOSITIONS AND USES THEREOF

ARYLCYCLOHEXYLAMINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS

CDK2 INHIBITORS

RHO KINASE INHIBITOR BA-1049 (R) AND ACTIVE METABOLITES THEREOF

Non-distillative Process for Manufacturing High Purity Amphetamines

Reagents for quantitative mass spectrometry

Deuterated tryptamine derivatives and methods of use

Synthesis of (R)(+)-2-(4-chloro-2-methyl phenoxy)propanoic acid in high enantiomeric excess

(S)-3-AMINO-4-(DIFLUOROMETHYLENE)CYCLOHEXENE AND CYCLOHEXANE CARBOXYLIC ACID AND USES THEREOF AS SELECTIVE INACTIVATORS OF HUMAN ORNITHINE AMINOTRANSFERASE (hOAT)

PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES

TERTIARY ALCOHOLS AS PI3K-y INHIBITORS

Methods of Making Deuterium-Enriched N-Acetylcysteine Amide (D-NACA) and (2R,2R)-3,3-Disulfanediyl BIS(2-Acetamidopropanamide) (DINACA) and Using D-NACA and DINACA to Treat Diseases Involving Oxidative Stress

A hydroxycarboxylic acid for the treatment of cancer

PROCESS FOR THE PREPARATION OF 2-CYANOETHYL (4S)-4-(4-CYANO-2-METHOXY-PHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAPHTHYRIDINE-3-CARBOXYLATE BY RESOLUTION OF RACEMATES BY MEANS OF DIASTEREOMERIC TARTARIC ACID ESTERS

Novel Imine

LOW-LEAD AND LOW-ARSENIC BETA-HYDROXYBUTYRATE SALTS AND METHODS FOR PRODUCING THE SAME

MODULATORS OF PROTEIN PHOSPHATASE 2A (PP2A) AND METHODS USING SAME

NOVEL PHOSPHOROUS (V)-BASED REAGENTS, PROCESSES FOR THE PREPARATION THEREOF, AND THEIR USE IN MAKING STEREO-DEFINED ORGANOPHOSHOROUS (V) COMPOUNDS

NOVEL XANTHONE COMPOUND HAVING EXCELLENT ANTICANCER EFFECT

PROCESS FOR PRODUCING ACYLOXYMETHYL ESTERS OF (4S)-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAPHTHYRIDIN-3-CARBOXYLIC ACID

NON-COVALENT DIMER CATION, SALT THEREOF, PREPARATION METHOD THEREOF, AND USE THEREOF AS ANTIOXIDANT

TRICYCLIC COMPOUNDS AND USES THEREOF

A PHARMACEUTICAL SALT OF AN ARYLPYRROLE DERIVATIVE

SUBSTITUTED AZACYLES AS TRMP8 MODULATORS

Asymmetric Constrained Geometry Catalysts

CHIRAL OR RACEMIC PYRIMIDINE-FUSED DIAZEPINONE DERIVATIVES, PREPARATION METHOD, AND APPLICATION THEREOF

P2X7 modulators

METHOD FOR PREPARING AN ENANTIOMERICALLY ENRICHED FORM OF 2-[2-(2-CHLOROTHIAZOL-5-YL)-2-HYDROXY-ETHYL]SULFANYL-6-HYDROXY-3-METHYL-5-PHENYL-PYRIMIDIN-4-ONE

COMPOSITIONS AND METHODS RELATED TO BICYCLO[2.2.1] HEPTANAMINE-CONTAINING COMPOUNDS

Compositions of trofinetide

METHOD FOR THE PREPARATION OF TRIS-(3-HYDROXYBUTYRATO)-GLYCERYL ESTER

PROCESS FOR THE DIASTEREOMERICALLY PURE PREPARATION OF DL/LD-METHIONYLMETHIONINE

COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES AND DISORDERS

METHOD FOR PREPARING CHIRAL NITRO DERIVATIVES USING ORGANIC CHIRAL CATALYST COMPOUNDS AND ECO-FRIENDLY SOLVENTS

SMALL MOLECULES FOR BORON NEUTRON CAPTURE THERAPY

Deuterated tryptamine derivatives and methods of use

CENTRAL CHIRALITY INDUCED SPIRO CHIRAL TETRADENTATE CYCLOMETALATED PLATINUM (II) AND PALLADIUM (II) COMPLEX-BASED CIRCULARLY POLARIZED LUMINESCENCE MATERIAL AND APPLICATION THEREOF

SUBSTITUTED PYRIMIDINE DERIVATIVES AS NICOTINIC ACETYLCHOLINESTERASE RECEPTOR ALPHA 6 MODULATOR

METHODS FOR TREATING SPINOCEREBELLAR ATAXIA TYPE 3

(R)-2-[(2H-1,3-benzodioxol-5-yl)methyl]pyrrolidine and processes for preparation, compositions and uses thereof

ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES

METHODS FOR TREATING SPINOCEREBELLAR ATAXIA TYPE 3

SULPHAMOYL UREA DERIVATIVES CONTAINING ALKYL-OXACYCLOALKYL MOIETY AND USES THEREOF

HPK1 ANTAGONISTS AND USES THEREOF

METHOD OF SYNTHESIS

METHOD OF MAKING AND/OR ISOLATING ISOIDIDE, COMPRISING SELECTIVE ESTERIFICATION OF A MIXTURE OF DIANHYDROHEXITOL ISOMERS

Exatecan derivatives, linker-payloads, and conjugates and thereof

RADIOLABELED COMPOUNDS TARGETING THE PROSTATE-SPECIFIC MEMBRANE ANTIGEN

PROCESS FOR THE PREPARATION OF A CHIRAL TRIOL

PROCESS FOR THE PREPARATION OF BRIVARACETAM

NOVEL CAMPTOTHECIN DERIVATIVE, COMPOSITION COMPRISING SAME AND USE THEREOF

NEW SYNTHESIS OF L-PHENYLALANINE AMIDE

MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

ILLUDIN ANALOGS, USES THEREOF, AND METHODS FOR SYNTHESIZING THE SAME

RUTHENIUM COMPLEX, PRODUCTION METHOD OF THE COMPLEX, AND PRODUCTION METHOD OF OPTICALLY ACTIVE SECONDARY ALCOHOLS USING THE COMPLEX AS CATALYST

PROCESS FOR RACEMIZING AND ISOLATING ATROPISOMERS OF 7-CHLORO-6-FLUORO-1-(2-ISOPROPYL-4-METHYLPYRIDIN-3-YL)PYRIDO[2,3-D]PYRIMIDINE-2,4(1H,3H)-DIONE

NOVEL PROCESS FOR PREPARING SOLRIAMFETOL HYDROCHLORIDE

COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE

ENANTIOMERICALLY PURIFIED GPER AGONIST FOR USE IN TREATING DISEASE STATES AND CONDITIONS

Methods of Making Deuterium-Enriched N-Acetylcysteine Amide (D-NACA) and (2R,2R)-3,3-Disulfanediyl BIS(2-Acetamidopropanamide) (DINACA) and Using D-NACA and DINACA to Treat Diseases Involving Oxidative Stress

DIOL DESYMMETRIZATION BY NUCLEOPHILIC AROMATIC SUBSTITUTION

INHIBITORS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS AND METAPNEUMO VIRUS

Solid form of (−)-Ambrox formed by a bioconversion of homofarnesol in the presence of a biocatalyst

LSD DERIVATIVES, SYNTHESIS & METHOD FOR TREATMENT OF DISEASES AND DISORDERS

Process of making derivatives of substituted morpholines

Deuterated tryptamine derivatives and methods of use

Serotonin Receptor Modulators

Anti-influenza virus pyrimidine derivatives

STEREOSELECTIVE MANUFACTURE OF SELECTED PURINE PHOSPHORAMIDATES

HETEROCYCLIC GLP-1 AGONISTS

Method for the production of lumateperone and its salts

COMPOSITION OF COMPOUNDS THAT MODULATE CELL METABOLISM AND METHODS OF USE

PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED JAK INHIBITORS

PHARMACEUTICAL COMPOSITIONS COMPRISING MACROLIDE DIASTEREOMERS, METHODS OF THEIR SYNTHESIS AND THERAPEUTIC USES

SUBSTITUTED (PHTHALAZIN-1-YLMETHYL)UREAS, SUBSTITUTED N-(PHTHALAZIN-1-YLMETHYL)AMIDES, AND ANALOGUES THEREOF

NOVEL AMINO ACID DERIVATIVES

PROCESS FOR PRODUCING (R)-3-HYDROXYBUTYL (R)-3-HYDROXYBUTYRATE

Diaryl macrocycle polymorph

PROCESS OF MAKING DERIVATIVES OF SUBSTITUTED MORPHOLINES

HETEROCYCLIC IMMUNOMODULATOR

Methods, processes, and compositions for improved preparation of HU308 and HU433

IRAK4 degraders and synthesis thereof

ADVANTAGEOUS TRYPTAMINE COMPOSITIONS FOR MENTAL DISORDERS OR ENHANCEMENT

ANTIVIRAL USE OF FABP4 MODULATING COMPOUNDS

Diamine derivatives as inhibitors of leukotriene Ahydrolase

SUBSTITUTED PHENYL-1H-PYRROLO[2,3-c] PYRIDINE DERIVATIVES

Phthalazinone compound, and preparation method therefor and medical use thereof

DEUBIQUITINASE INHIBITORS AND METHODS OF USE THEREOF

Pyridine acetamide derivative serving as CDK inhibitor, and preparation method therefor and use thereof

LSD DERIVATIVES, SYNTHESIS & METHOD FOR TREATMENT OF DISEASES AND DISORDERS

Deuterated tryptamine derivatives and methods of use

HALOGENATED DERIVATIVES OF MORPHINANS AND USES THEREOF

COVALENT INHIBITORS OF KRAS

Deuterated tryptamine derivatives and methods of use

Polycyclic amide derivative as CDK9 inhibitor, preparation method therefor and use thereof

Small molecule inhibitors of galectin-3

N-(HETEROCYCLYL AND HETEROCYCLYLALKYL)-3-BENZYLPYRIDIN-2-AMINE DERIVATIVES AS SSTR4 AGONISTS

METHOD FOR PREPARATION OF TRANS-N-BENZYLOXYCARBONYL-(3-HYDROXY-2-PIPERIDINYL)-2-PROPANONE AS INTERMEDIATE OF HALOFUGINONE

MODULATORS OF HEMOGLOBIN

LIPOPHILIC ENANTIOMERS OF DESACETYLGLUCOSAMINE MURAMYL DIPEPTIDE WITH ANTI-INFLAMMATORY AND GROWTH PROMOTING ACTIVITY

Indole alkaloid compound in noni enzyme and preparation method and application thereof

KINASE INHIBITORS

METHOD FOR PREPARING CHIRAL 4-ARYL-ß-AMINO ACID DERIVATIVE

Crystalline Forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride

SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION

(S,Z)-3,7-DIMETHYLNON-6-EN-1-OL AND ITS USE AS FRAGRANCE

Bcl-2 inhibitor

Amines for use as sigma receptor modulators

Compound or its salt thereof targeting fibroblast activation protein, its preparation methods and its uses thereof

PROCESS FOR PRODUCING 4,5-DIHYDRO-1H-PYRAZOLES AND INTERMEDIATES

STEREOISOMER OF EPOXY COMPOUND, CURABLE COMPOSITION CONTAINING THE SAME, AND CURED PRODUCT OBTAINED BY CURING CURABLE COMPOSITION

Preparation method for and application of chiral spirocyclic phosphine-nitrogen-phosphine tridentate ligand and iridium catalyst thereof

INHIBITORS OF ANTIGEN PRESENTATION BY HLA-DR

ATROPISOMERS OF PYRIDAZINONE DERIVATIVES AS HERBICIDES

HYDROGENATION OF L-SORBOSE

Substituted aminothiazoles as DGKzeta inhibitors for immune activation

6-MEMBERED HETEROARYLAMINOSULFONAMIDES FOR TREATING DISEASES AND CONDITIONS MEDIATED BY DEFICIENT CFTR ACTIVITY

Compositions and methods for treating and preventing neurodegenerative disorders

REAGENTS FOR QUANTITATIVE MASS SPECTROMETRY

PHTHALAZINONE COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF

SPIRO RING-CONTAINING QUINAZOLINE COMPOUND

MACROCYCLIC RIP2-KINASE INHIBITORS

MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

OXAZINE MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS

PROTEIN DEGRADATION AGENT COMPOUND PREPARATION METHOD AND APPLICATION

SUBSTITUTED BICYCLIC AND TRICYCLIC UREAS AND AMIDES, ANALOGUES THEREOF, AND METHODS USING SAME

Method For Preparing (S)-1,2,3,4-Tetrahydroisoquinoline-1 Carboxylic Acid and Derivatives Thereof

PROCESS FOR THE SYNTHESIS OF S-BEFLUBUTAMID USING ASYMMETRIC HYDROGENATION

QUINUCLIDINONE ANALOGUES AS ANTICANCER AGENTS

METHOD FOR THE PREPARATION OF N-MONOFLUOROALKYL TROPANES AND THEIR USE

Method of preparing high chiral purity lactam intermediate and brivaracetam

Deuterated tryptamine derivatives and methods of use

HETEROCYCLIC DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THE TREATMENT OR AMELIORATION OF CANCER

PREPARATION METHOD OF A HIGH-OPTICAL-PURITY CHIRAL OXO-AZA-CYCLOALKANE COMPOUND

EGFR inhibitors

FUNCTIONALIZED HETEROCYCLIC COMPOUNDS AS MODULATORS OF STIMULATOR OF INTERFERON GENES (STING)

Picolinamides as fungicides

PROCESS FOR THE PREPARATION OF (9S)-2-BROMO-9-(2,3,4-TRIFLUOROPHENYL)-6,7,8,9-TETRAHYDRO-5H-[1,2,4]TRIAZOLO[1,5-A]AZEPINE

SUBSTITUTED THIOPHENE CARBOXAMIDES, THIOPHENE CARBOXYLIC ACIDS AND DERIVATIVES THEREOF

FLUORINE-CONTAINING HETEROCYCLIC DERIVATIVES WITH MACROCYCLIC STRUCTURE AND USE THEREOF

Preparation method for optically active citronellal

CHIRAL GUANIDINES, SALTS THEREOF, METHODS OF MAKING CHIRAL GUANIDINES AND SALTS THEREOF, AND USES OF CHIRAL GUANIDINES AND SALTS THEREOF IN THE PREPARATION OF ENANTIOMERICALLY PURE AMINO ACIDS

EGFR inhibitors

VINYLETHER COMPOUNDS AND PROCESSES FOR PREPARING ALDEHYDE COMPOUNDS AND A CARBOXYLATE COMPOUND THEREFROM

ACC INHIBITOR AND USE THEREOF

LEFT-HANDED BICYCLIC MORPHOLINE AND SALT THEREOF, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND USE

Conversion of THC, CBD and their derivatives to Cannabinol

Synthesis of eribulin mesylate

N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2

AN INDUSTRIAL PROCESS FOR RESOLUTION OF CHLOCYPHOS

Alcohol derivatives as Kv7 potassium channel openers

SYNTHESIS METHOD FOR HALOFUGINONE AND HALOFUGINONE INTERMEDIATES

Heterocyclic compounds as modulators of mGluR7

Pharmaceutical compositions comprising monoterpenes

Class of phosphine nitrogen ligand with multiple chiral centers and its synthesis method and application

COMPOSITIONS AND METHODS FOR PREPARING REGIO- AND STEREOSELECTIVE ALICYCLIC ALKENE ISOTOPOLOGUES AND STEREOISOTOPOMERS

Compositions of trofinetide

Oxygen-containing Heterocyclic Compound, Preparation Method Therefor and Use Thereof

PROCESS FOR PREPARING (R)-4-AMINOINDANE AND CORRESPONDING AMIDES

METHOD OF PRODUCING L-GLUFOSINATE

IMPROVED ENANTIOSELECTIVE HYDROGENATION OF 4-SUBSTITUTED 1,2-DIHYDROQUINOLINES IN PRESENCE OF A CHIRAL IRIDIUM CATALYST AND AN ADDITIVE

Compositions For Preventing And/Or Treating Degenerative Disorders Of The Central Nervous System And/Or Lysosomal Storage Disorders

Himastatin derivatives, and processes of preparation thereof, and uses thereof

Salts of the Janus Kinase Inhibitor (R)-3-(4-(7h-Pyrrolo[2,3-D]Pyrimidin-4-YL)-1h-Pyrazol-1-Yl)-3- Cyclopentylpropanenitrile

Process for the synthesis of non-racemic cyclohexenes

Polycyclic carbogenic molecules and uses thereof as anti-cancer agents

SUBSTITUTED DIAZAHETERO-BICYCLIC COMPOUNDS AND THEIR USE

Methods of synthesis of (1R,2R,5R)-5-amino-2-methyl-cyclohexanol hydrochloride and intermediates useful therein

Scalable synthesis of dual-target inhibitor of cannabinoid-1 receptor and inducible nitric oxide synthase

Heterogeneous catalysts for substrate-directed hydrogenation and methods of producing such catalysts

Tertiary alcohols as PI3K-γ inhibitors

P2X7 modulators

METHODS OF TREATING NEUROLOGICAL AND OTHER DISORDERS USING ENANTIOPURE DEUTERIUM-ENRICHED BUPROPION

ARGININE GINGIPAIN INHIBITORS

BIASED AGONISTS OF OPIOID RECEPTORS

Method for resolving optical isomer by using supercritical fluid extraction technology

Methods for producing D-α-methyldopa

Synthesis and use of oxa-spirodiphosphine ligand

Solid form of (-)-Ambrox formed by a bioconversion of homofarnesol in the presence of a biocatalyst

Methods of carbon-carbon bond fragmentation

CRYSTALLINE FORMS OF NEUROTROPHIN MIMETIC COMPOUNDS AND THEIR SALTS

5,6,7,7a-tetrahydrocyclopenta[f]pyrido[1,2-h][1,7]naphthyridin-11(4bH)-one compounds and methods of use

Anti-influenza virus pyrimidine derivative

Ethynyl derivatives

SOLID STATE FORMS OF VALBENAZINE

Glycosyl donor, preparation method therefor, and use thereof

Intermediates for optically active piperidine derivatives and preparation methods thereof

METHOD FOR PRODUCING OPTICALLY ACTIVE PYRROLIDINE COMPOUNDS

METHODS AND COMPOSITIONS FOR SUBSTITUTED AXIALLY-CHIRAL CANNABINOL ANALOGS

ENANTIOMERICALLY PURIFIED GPER AGONIST FOR USE IN TREATING DISEASE STATES AND CONDITIONS

Rho kinase inhibitor BA-1049 (R) and active metabolites thereof

Process for the preparation of enantiomerically pure norepinephrine

N-AZASPIROCYCLOALKANE SUBSTITUTED N-HETEROARYL COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2

KDM1A inhibitors for the treatment of disease

Solid forms of a thienopyrimidinedione ACC inhibitor and methods for production thereof

Method for directly constructing highly optically active tetrasubstituted allenic acid compounds

Enantiomerically enriched, polycrystalline molecular sieves

Compositions of trofinetide

Anticancer indenes, indanes, azaindenes, azaindanes, pharmaceutical compositions and uses

IMPROVEMENT IN OR RELATING TO ORGANIC COMPOUNDS

Method for preparing brivaracetam and intermediate thereof

Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use

Compounds derived from and uses thereof

Process for preparing an optically active cineole derivative

Enantiomerically purified GPER agonist for use in treating disease states and conditions

METHOD FOR PREPARING (2S,3S)-3-AMINO-BICYCLO[2.2.2]OCTANE-2-CARBOXYLATE

L-glufosinate intermediate and L-glufosinate preparation method

Preparation method for deuterated macrocyclic compound

Reagents for quantitative mass spectrometry

Indazolylcyanoethylamino compound, compositions of same, method of making, and methods of using thereof

Compounds for modulating mitochondrial function

Process for preparing sulfonamide compounds

Di-, tri- and tetraphenylindane derivates and their use in organic electronics

Cell metabolism modulating compounds and uses thereof

PROCESSES FOR PREPARING NITROSYLATED PROPANEDIOLS, COMPOSITIONS COMPRISING THE SAME, AND MEDICAL USES THEREOF

PHOTOPROTECTIVE MIXTURES AS IMAGING REAGENTS IN SEQUENCING-BY-SYNTHESIS

COMPOUNDS FOR A CONTROLLED RELEASE OF ACTIVE PERFUMING MOLECULES

METHODS OF TREATING NEUROLOGICAL AND OTHER DISORDERS USING ENANTIOPURE DEUTERIUM-ENRICHED BUPROPION

(S)-ENANTIOMERIC FORM OF A HETEROCYCLIC COMPOUND HAVING MOTIVATION IMPROVING AND/OR REFERENCE MEMORY ENHANCING ACTIVITY

Method of separating α-olefin by a simulated moving bed

N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2

Reactor for carrying out a gas-liquid two-phase high-pressure reaction with a foaming medium

SET8 lysine methyltransferase inhibitor and preparation method and application thereof

Compound of 3,3,3′,3′-tetramethyl-1,1′-spirobiindane-based bisoxazoline ligand, intermediate thereof, preparation method thereof and use thereof

Preparation method for high optical indoxacarb intermediate

NEW AMINO-PYRIMIDONYL-PIPERIDINYL DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

PROCESS FOR PREPARING A NOVEL PHENICOL ANTIBACTERIAL AGENT

Method for manufacturing cyclopropane compound

P62 ligand compound, and composition for preventing, ameliorating or treating proteinopathies comprising the same

A PROCESS FOR THE PREPARATION OF OZANIMOD AND ITS INTERMEDIATE (S)-l-AMINO-2,3-DIHYDRO-1H-INDENE-4-CARBONITRILE

Processes for the production of isomerically pure or enriched cis-clomiphene

Dissymmetric N,N-dialkylamides used particularly for separating uranium(VI) from plutonium(IV), synthesis thereof and uses of same

OPTICALLY ACTIVE SEGMENT FOR USE IN SYNTHESIS OF STEREOCONTROLLED OLIGONUCLEOTIDE, METHOD FOR PRODUCING THE SAME, AND METHOD FOR SYNTHESIZING STEREOCONTROLLED OLIGONUCLEOTIDE USING THE SAME

Vasopressin receptor antagonists and products and methods related thereto

Optically-active cyclopentenone derivatives

Method for producing optically active pyrrolidine compounds

MODULATORS OF ROR-GAMMA

Substituted indoline derivatives as dengue viral replication inhibitors

AUTOTAC chimeric compound, and composition for preventing, ameliorating or treating diseases through targeted protein degradation comprising the same

DEUTERATED ALVOCIDIB AND ALVOCIDIB PRODRUGS

Phthalide derivative, preparation method and use thereof

CDK2 inhibitors

1,2,4-triazole derivatives as tankyrase inhibitors

Anticancer indenes, indanes, azaindenes, azaindanes, pharmaceutical compositions and uses

SHORT-ACTING BENZODIAZEPINE SALTS AND THEIR POLYMORPHIC FORMS

CDK2 inhibitors

Compound and use thereof in synthesis of brivaracetam intermediate and crude drug